MSU
TDAC

Mizuho Securities USA’s Translational Development Acquisition Corp TDAC Stock Holding History

Mizuho Securities USA’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Sell
328,012
-73,088
-18% -$781K 0.06% 309
2026
Q1 		$4.2M Buy
401,100
+34,990
+10% +$369K 0.1% 228
2025
Q4 		$3.79M Buy
366,110
+3,122
+0.9% +$32.5K 0.06% 269
2025
Q3 		$3.74M Sell
362,988
-187,952
-34% -$1.94M 0.08% 265
2025
Q2 		$5.62M Sell
550,940
-24,060
-4% -$244K 0.12% 179
2025
Q1 		$5.78M Buy
+575,000
New +$5.78M 0.12% 170

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.39% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.56% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return

Mizuho Securities USA's TDAC Position: Q2 2026 in Review

Mizuho Securities USA reduced its Translational Development Acquisition Corp (TDAC) stake by 18% in Q2 2026, selling an estimated $781K and leaving 328,012 shares worth $3.5M. The position accounts for 0.06% of the portfolio, ranked #309.

Mizuho Securities USA first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.78M in Q1 2025. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Mizuho Securities USA held 328,012 shares of Translational Development Acquisition Corp worth $3.5M as of Q2 2026.
  • Mizuho Securities USA sold 73,088 Translational Development Acquisition Corp shares in Q2 2026, an estimated $781K.
  • Translational Development Acquisition Corp made up 0.06% of Mizuho Securities USA's portfolio in Q2 2026, its #309 holding.
  • Mizuho Securities USA first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • Mizuho Securities USA's Translational Development Acquisition Corp position peaked at $5.78M in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.